275 AI Citations in 30 Days: How Proprietary Clinical Data Wins Visibility in AI Search
Industry: Digital Health
Executive Summary
A natural weight loss supplement brand needed to break through in an AI-dominated search landscape where pharmaceutical brands and established medical sites controlled the conversation around appetite suppressants. With newly published clinical trial data proving their product’s effectiveness, they partnered with Fire&Spark to transform proprietary research into AI-citable content that would position them as the authoritative source on natural appetite suppression.
Fire&Spark built a content piece anchored in the client’s own human clinical trial data, designed not just to rank, but to become the source AI models cite when answering questions about natural weight loss alternatives.
Within 30 days of launch, the content achieved 275 citation instances across major AI platforms, claimed position 1 on 14 of 20 tracked prompts, and dominated the trust and safety category with 108 citations.
Client Background
The client is a science-backed natural supplement brand operating in the competitive weight loss category. Their flagship product contains a patented plant-based extract supported by multiple peer-reviewed clinical trials, including a six-month randomized, double-blind, placebo-controlled study—a rarity in the natural supplement space.
The brand competes with both prescription medications like semaglutide (Wegovy/Ozempic) and tirzepatide (Zepbound/Mounjaro), as well as countless natural supplements making unsupported claims. Their differentiation lies in rigorous clinical evidence showing fat loss with muscle preservation. But this scientific authority meant nothing if AI models weren’t surfacing their brand when consumers asked about weight loss alternatives.
AI Citations in 30 Days


